← All candidates
75 insider filings on record.
75 filings on record.
VORVor Biopharma Inc.
NasdaqGS · Healthcare · $1.32B
$22.32
-3.29% · Sep 15
75 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 58 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what VOR ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.32B
Float
37.2M
63% public
Short % float
Pro
Price / profit
0.1
Price / future profit
—
Price / sales
—
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
70 more transactions on Pro →Context
Wall St
$37.88 avg target
+69.7% vs today · 8 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.73 act+$0.06
Q4 '25$307.53 act+$308.72
Q3 '25−$121.63 act−$117.53
Q2 '25−$251.20 act−$239.40
Coverage
Why Vor Biopharma (VOR) Is Up 24.5% After Broad FTSE Russell Index Inclusion And What's NextSimply Wall St. · 06-30We're Hopeful That Vor Biopharma (NASDAQ:VOR) Will Use Its Cash WiselySimply Wall St. · 05-15Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to TradeZacks · 05-07Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?Zacks · 04-20
The file stays open
75 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice